Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis

1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3. 11416722.

2. Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339–47. doi: 10.1086/427192 15633092.

3. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS ONE. 2010;5(9):e12598. doi: 10.1371/journal.pone.0012598 20856886; PubMed Central PMCID: PMCPMC2938354.

4. Martin M, Del Cacho E, Codina C, Tuset M, De Lazzari E, Mallolas J, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24(10):1263–8. doi: 10.1089/aid.2008.0141 18834323.

5. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43(1):78–84. doi: 10.1097/01.qai.0000225015.43266.46 16878045.

6. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051–8. 11953472.

7. Kim SH, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS. 2014;28(13):1945–56. doi: 10.1097/QAD.0000000000000316 24845154; PubMed Central PMCID: PMCPMC4162330.

8. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52. doi: 10.1097/QAD.0b013e328359590f 22951634.

9. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296(6):679–90. doi: 10.1001/jama.296.6.679 16896111.

10. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438. doi: 10.1371/journal.pmed.0030438 17121449; PubMed Central PMCID: PMCPMC1637123.

11. Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. PLoS ONE. 2014;9(11):e111421. doi: 10.1371/journal.pone.0111421 25372479; PubMed Central PMCID: PMCPMC4221025.

12. Kanters S, Park JH, Chan K, Socias ME, Ford N, Forrest J, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and meta-analysis. Lancet HIV. 2016. Published online November 15.

13. WHO. Consolidated guideliens on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. WHO, Geneva: 2nd Edition. 2016.

14. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097 19621072; PubMed Central PMCID: PMC2707599.

15. Roberts I, Kerr K. How systematic reviews cause research waste. Lancet. 2015 Oct 17;386(10003):1536. doi: 10.1016/S0140-6736(15)00489-4 26530621.

16. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66. doi: 10.1080/09540120050042891 10928201.

17. Freeman MF TJ. Transformations Related to the Angular and the Square Root. Annals of Mathematical Statistics 1950. 21: 607–611.

18. Miller J. The Inverse of the Freeman-Tukey Double Arcsine Transformation. The American Statistician. 1978. 32: 138.

19. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2(2):121–45. Epub 1993/01/01. 8261254

20. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I2 in assessing heterogeneity may mislead. BMC medical research methodology. 2008; 8:79. doi: 10.1186/1471-2288-8-79 19036172

21. Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15. doi: 10.1086/521250 17806060

22. Patel DA, Snedecor SJ, Tang WY, Sudharshan L, Lim JW, Cuffe R, et al. 48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. PLoS ONE. 2014;9(9):e105653. doi: 10.1371/journal.pone.0105653 25188312; PubMed Central PMCID: PMCPMC4154896.

23. Kredo T, Ford N, Adeniyi FB, Garner P. Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev. 2013;6:CD009987. doi: 10.1002/14651858.CD009987.pub2 23807693.

24. Apollo T, Ford N, Eugenia S, Mathew W, Mills EJ, Kanters S. Effect of frequency of clinic visits and medication pick-up on antiretroviral therapy outcomes: a systematic review and meta-analysis. Abstract THUAE0804. 18th International cnference on AIDS and STIs in Africa Harare, November 29th—December 4th. 2015.

25. Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443–50. 18077833; PubMed Central PMCID: PMCPMC2666542.

26. Sin NL, DiMatteo MR. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med. 2014;47(3):259–69. doi: 10.1007/s12160-013-9559-6 24234601; PubMed Central PMCID: PMCPMC4021003.

27. Honagodu AR, Krishna M, Sundarachar R, Lepping P. Group psychotherapies for depression in persons with HIV: A systematic review. Indian J Psychiatry. 2013;55(4):323–30. doi: 10.4103/0019-5545.120541 24459301; PubMed Central PMCID: PMCPMC3890933.

28. Crepaz N, Passin WF, Herbst JH, Rama SM, Malow RM, Purcell DW, et al. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons' mental health and immune functioning. Health Psychol. 2008;27(1):4–14. doi: 10.1037/0278-6133.27.1.4 18230008.

29. Musiime V, Fillekes Q, Kekitiinwa A, Kendall L, Keishanyu R, Namuddu R, et al. The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children. J Acquir Immune Defic Syndr. 2014;66(2):148–54. doi: 10.1097/QAI.0000000000000135 24828266.

30. Ramjan R, Calmy A, Vitoria M, Mills EJ, Hill A, Cooke G, et al. Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy. Trop Med Int Health. 2014;19(5):501–13. doi: 10.1111/tmi.12297 24628918.

31. Ryan GW, Wagner GJ. Pill taking 'routinization': a critical factor to understanding episodic medication adherence. AIDS Care. 2003;15(6):795–806. doi: 10.1080/09540120310001618649 14617501.

32. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012;15(2):17383. doi: 10.7448/IAS.15.2.17383 23199799; PubMed Central PMCID: PMCPMC3503237.

33. Anon. Empty Shelves, Come Back Tomorrow–ARV Stock Outs Undermine Efforts to Fight HIV. MSF, Johannesburg, 2015 Available http://wwwmsforg/sites/msforg/files/msf_out_of_stocks_low_respdf.

34. Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS research and human retroviruses. 2008;24(8):1031–5. 18724803. doi: 10.1089/aid.2008.0035

35. Glass TR, Rotger M, Telenti A, Decosterd L, Csajka C, Bucher HC, et al. Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy. PLoS ONE. 2012;7(1):e29186. 22235271. doi: 10.1371/journal.pone.0029186

36. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization: Geneva. Available at: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf?ua=1. 2015.

37. Al-Dakkak I1, Patel S, McCann E, Gadkari A, Prajapati G, Maiese EM. The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: a systematic review and meta-analysis. AIDS Care. 2013;25(4):400–14. doi: 10.1080/09540121.2012.712667 22908886.

38. Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, Gallant JE, Mugavero MJ, Mills EJ, Giordano TP. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis. 2014 May;58(9):1297–307.24457345. doi: 10.1093/cid/ciu046

39. Ford N, Flexner C, Vella S, Ripin D, Vitoria M. Optimization and simplification of antiretroviral therapy for adults and children. Curr Opin HIV AIDS. 2013 Nov;8(6):591–9. doi: 10.1097/COH.0000000000000010 24100871.

40. Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdottir TB, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 2014;12:142. doi: 10.1186/PREACCEPT-1453408941291432 25145556; PubMed Central PMCID: PMCPMC4148019.

41. Ferrand RA, Briggs D, Ferguson J, Penazzato M, Armstrong A, MacPherson P, et al. Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges. Trop Med Int Health. 2016;21(3):325–33. doi: 10.1111/tmi.12656 26681359; PubMed Central PMCID: PMCPMC4776345.

42. Shaw S, Amico KR. Antiretroviral therapy adherence enhancing interventions for adolescents and young adults 13 to 24 years of age: A review of the evidence base. J Acquir Immune Defic Syndr. 2016. doi: 10.1097/QAI.0000000000000977 26959190.

43. Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012;14(2):e51. doi: 10.2196/jmir.2015 22481246; PubMed Central PMCID: PMCPMC3376506.

44. Dowshen N, Kuhns LM, Gray C, Lee S, Garofalo R. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS Behav. 2013;17(6):2237–43. doi: 10.1007/s10461-013-0464-6 23546844.

45. Nachega JB J, Skinner D, Jennings L, Magidson JF, Altice FL, Burke JG, Lester RT, Uthman OA, Knowlton AR, Cotton MF, Anderson JR, Theron GB. Acceptability and feasibility of mHealth and community-based patient nominated treatment supporter to prevent mother-to-child HIV transmission in South African pregnant women under Option B+: an exploratory study. Patient Preference and Adherence. 2016; 28(10):683–90.

46. Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Barnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28 Suppl 2:S187–204. doi: 10.1097/QAD.0000000000000252 24849479.

47. Buchanan AL, Montepiedra G, Sirois PA, Kammerer B, Garvie PA, Storm DS, et al. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244–51. doi: 10.1542/peds.2011-1740 22508915; PubMed Central PMCID: PMCPMC3340587.